FEDERALSEC 10-K Item 1CFirst filing
Filed Jul 1, 2024bd_48aac93b7a615dd3
Elite Pharmaceuticals' Form 10-K Item 1C cybersecurity disclosure describes the company's cyber risk management program aligned to the NIST Cybersecurity Framework, including annual third-party risk assessments, IPS/IDS controls, identity access management, data backups, and Audit Committee oversight. The Company states it is not aware of any cybersecurity risks that have materially affected or are reasonably likely to materially affect its business. No specific incident is disclosed.